STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function

Journal of Experimental Medicine

Volumn 212, Issue 6, 2015, Pages 855-864

  Wilson, Robert P ^a,b   Ives, Megan L ^b,c   Rao, Geetha ^b   Lau, Anthony ^a,b   Payne, Kathryn ^b   Kobayashi, Masao ^d   Arkwright, Peter D ^e   Peake, Jane ^f   Wong, Melanie ^g   Adelstein, Stephen ^h   Smart, Joanne M ⁱ   French, Martyn A ^j,k   Fulcher, David A ^l   Picard, Capucine ^m,n   Bustamante, Jacinta ^m,n   Boisson Dupuis, Stephanie ^m,o   Gray, Paul ^c   Stepensky, Polina ^p   Warnatz, Klaus ^q   Freeman, Alexandra F ^r   Rossjohn, Jamie ^s,t   McCluskey, James ^u   Holland, Steven M ^r   Casanova, Jean Laurent ^m,n,o,v   Uzel, Gulbu ^r   Ma, Cindy S ^b,c   Tangye, Stuart G ^b,c   Deenick, Elissa K ^b,c   more..

^a UNIVERSITY OF BATH   (United Kingdom)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d HIROSHIMA UNIVERSITY   (Japan)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ ROYAL CHILDREN'S HOSPITAL   (Australia)

^j ROYAL PERTH HOSPITAL   (Australia)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l WESTMEAD HOSPITAL   (Australia)

^m IMAGINE INSTITUTE   (France)

ⁿ HÔPITAL NECKER ENFANTS MALADES   (France)

^o ROCKEFELLER UNIVERSITY   (United States)

^p HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^q UNIVERSITY OF FREIBURG   (Germany)

^r NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^s MONASH UNIVERSITY   (Australia)

^t CARDIFF UNIVERSITY   (United Kingdom)

^u UNIVERSITY OF MELBOURNE   (Australia)

^v HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; CYTOKINE; IL12RB1 PROTEIN, HUMAN; IL23R PROTEIN, HUMAN; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; RORC PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GAMMA DELTA T LYMPHOCYTE; GENE; HUMAN; HUMAN CELL; IL12RB1 GENE; IL21R GENE; IMMUNE DEFICIENCY; LOSS OF FUNCTION MUTATION; LYMPHOCYTE FUNCTION; MOSAICISM; MUCOSAL ASSOCIATED INVARIANT T CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAT3 GENE; T LYMPHOCYTE; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; LYMPHOCYTE; METABOLISM; MONONUCLEAR CELL; MUTATION; NATURAL KILLER CELL; SINGLE NUCLEOTIDE POLYMORPHISM;

CELL SEPARATION; CYTOKINES; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKINS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MUTATION; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RECEPTORS, INTERLEUKIN-21; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84980000578     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20141992     Document Type: Article

References (43)

1. Acosta-Rodriguez, E.V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8:639-646. http://dx.doi.org/10.1038/ ni1467
2. Bonneville, M., R.L. O'Brien, and W.K. Born. 2010. γδT cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10:467-478. http://dx.doi.org/10.1038/nri2781
3. Chandesris, M.-O., I. Melki, A. Natividad, A. Puel, C. Fieschi, L. Yun, C. Thumerelle, E. Oksenhendler, D. Boutboul, C. Thomas, et al. 2012. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore). 91:e1-e19. http://dx.doi.org/10.1097/MD .0b013e31825f95b9
4. Chien, Y.H., C. Meyer, and M. Bonneville. 2014. γδT cells: first line of defense and beyond. Annu. Rev. Immunol. 32:121-155. http://dx.doi .org/10.1146/annurev-immunol-032713-120216
5. Cho, J.S., E.M. Pietras, N.C. Garcia, R.I. Ramos, D.M. Farzam, H.R. Monroe, J.E. Magorien, A. Blauvelt, J.K. Kolls, A.L. Cheung, et al. 2010. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120:1762-1773. http://dx.doi .org/10.1172/JCI40891
6. Constantinides, M.G., and A. Bendelac. 2013. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25:161-167. http://dx.doi .org/10.1016/j.coi.2013.01.003
7. - NKT cell population. Proc. Natl. Acad. Sci. USA. 105:11287-11292. http://dx.doi.org/10.1073/pnas.0801631105
8. Corbett, A.J., S.B.G. Eckle, R.W. Birkinshaw, L. Liu, O. Patel, J. Mahony, Z. Chen, R. Reantragoon, B. Meehan, H. Cao, et al. 2014. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature. 509:361-365. http://dx.doi.org/10.1038/nature13160
9. Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10:479-489. http://dx.doi .org/10.1038/nri2800
10. Cypowyj, S., C. Picard, L. Maródi, J.-L. Casanova, and A. Puel. 2012. Immunity to infection in IL-17-deficient mice and humans. Eur. J. Immunol. 42: 2246-2254. http://dx.doi.org/10.1002/eji.201242605
11. de Beaucoudrey, L., A. Puel, O. Filipe-Santos, A. Cobat, P. Ghandil, M. Chrabieh, J. Feinberg, H. von Bernuth, A. Samarina, L. Jannière, et al. 2008. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J. Exp. Med. 205:1543-1550. http:// dx.doi.org/10.1084/jem.20080321
12. de Beaucoudrey, L., A. Samarina, J. Bustamante, A. Cobat, S. Boisson-Dupuis, J. Feinberg, S. Al-Muhsen, L. Jannière, Y. Rose, M. de Suremain, et al. 2010. Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore). 89:381-402. http://dx.doi.org/ 10.1097/MD.0b013e3181fdd832
13. Deenick, E.K., D.T. Avery, A. Chan, L.J. Berglund, M.L. Ives, L. Moens, J.L. Stoddard, J. Bustamante, S. Boisson-Dupuis, M. Tsumura, et al. 2013. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J. Exp. Med. 210:2739-2753. http://dx.doi.org/10.1084/jem.20130323
14. Dorman, S.E., C. Picard, D. Lammas, K. Heyne, J.T. van Dissel, R. Baretto, S.D. Rosenzweig, M. Newport, M. Levin, J. Roesler, et al. 2004. Clinical features of dominant and recessive interferon γ receptor 1 deficiencies. Lancet. 364:2113-2121. http://dx.doi.org/10.1016/S0140- 6736(04)17552-1
15. Durant, L., W.T. Watford, H.L. Ramos, A. Laurence, G. Vahedi, L. Wei, H. Takahashi, H.W. Sun, Y. Kanno, F. Powrie, and J.J. O'Shea. 2010. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity. 32:605-615. http://dx.doi .org/10.1016/j.immuni.2010.05.003
16. Dusseaux, M., E. Martin, N. Serriari, I. Péguillet, V. Premel, D. Louis, M. Milder, L. Le Bourhis, C. Soudais, E. Treiner, and O. Lantz. 2011. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood. 117:1250-1259. http://dx.doi.org/10 .1182/blood-2010-08-303339
17. Eidson, M., J. Wahlstrom, A.M. Beaulieu, B. Zaidi, S.E. Carsons, P.K. Crow, J. Yuan, J.D. Wolchok, B. Horsthemke, D. Wieczorek, and D.B. Sant'Angelo. 2011. Altered development of NKT cells, γδT cells, CD8 T cells and NK cells in a PLZF deficient patient. PLoS ONE. 6:e24441. http://dx.doi.org/10.1371/journal.pone.0024441
18. Fenoglio, D., A. Poggi, S. Catellani, F. Battaglia, A. Ferrera, M. Setti, G. Murdaca, and M.R. Zocchi. 2009. Vβ1 T lymphocytes producing IFN-γ and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood. 113:6611-6618. http://dx.doi.org/ 10.1182/blood-2009-01-198028
19. Gold, M.C., and D.M. Lewinsohn. 2013. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat. Rev. Microbiol. 11:14- 19. http://dx.doi.org/10.1038/nrmicro2918
20. Holland, S.M., F.R. DeLeo, H.Z. Elloumi, A.P. Hsu, G. Uzel, N. Brodsky, A.F. Freeman, A. Demidowich, J. Davis, M.L. Turner, et al. 2007. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357:1608- 1619. http://dx.doi.org/10.1056/NEJMoa073687
21. Hsu, A.P., K.J. Sowerwine, M.G. Lawrence, J. Davis, C.J. Henderson, K.A. Zarember, M. Garofalo, J.I. Gallin, D.B. Kuhns, T. Heller, et al. 2013. Intermediate phenotypes in patients with autosomal dominant hyper- IgE syndrome caused by somatic mosaicism. J. Allergy Clin. Immunol. 131:1586-1593. http://dx.doi.org/10.1016/j.jaci.2013.02.038
22. Ivanov, I.I., B.S. McKenzie, L. Zhou, C.E. Tadokoro, A. Lepelley, J.J. Lafaille, D.J. Cua, and D.R. Littman. 2006. The orphan nuclear receptor RORβt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 126:1121-1133. http://dx.doi.org/10.1016/ j.cell.2006.07.035
23. Ives, M.L., C.S. Ma, U. Palendira, A. Chan, J. Bustamante, S. Boisson- Dupuis, P.D. Arkwright, D. Engelhard, D. Averbuch, K. Magdorf, et al. 2013. Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T-cell memory formation and function. J. Allergy Clin. Immunol. 132:400-411: e9. http://dx.doi.org/10.1016/j.jaci.2013 .05.029
24. Kane, A., E.K. Deenick, C.S. Ma, M.C. Cook, G. Uzel, and S.G. Tangye. 2014. STAT3 is a central regulator of lymphocyte differentiation and function. Curr. Opin. Immunol. 28:49-57. http://dx.doi.org/10.1016/ j.coi.2014.01.015
25. Kjer-Nielsen, L., O. Patel, A.J. Corbett, J. Le Nours, B. Meehan, L. Liu, M. Bhati, Z. Chen, L. Kostenko, R. Reantragoon, et al. 2012. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 491: 717-723.
26. Kotlarz, D., N. Zietara, G. Uzel, T. Weidemann, C.J. Braun, J. Diestelhorst, P.M. Krawitz, P.N. Robinson, J. Hecht, J. Puchalka, et al. 2013. Lossof- function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 210:433-443. http://dx.doi .org/10.1084/jem.20111229
27. Kovalovsky, D., O.U. Uche, S. Eladad, R.M. Hobbs, W. Yi, E. Alonzo, K. Chua, M. Eidson, H.J. Kim, J.S. Im, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9:1055-1064. http://dx.doi.org/10.1038/ni.1641
28. Le Bourhis, L., Y.K. Mburu, and O. Lantz. 2013. MAIT cells, surveyors of a new class of antigen: development and functions. Curr. Opin. Immunol. 25:174-180. http://dx.doi.org/10.1016/j.coi.2013.01.005
29. Li, B., M.D. Rossman, T. Imir, A.F. Oner-Eyuboglu, C.W. Lee, R. Biancaniello, and S.R. Carding. 1996. Disease-specific changes in γδT cell repertoire and function in patients with pulmonary tuberculosis. J. Immunol. 157:4222-4229.
30. Ma, C.S., G.Y.J. Chew, N. Simpson, A. Priyadarshi, M. Wong, B. Grimbacher, D.A. Fulcher, S.G. Tangye, and M.C. Cook. 2008. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J. Exp. Med. 205:1551-1557. http://dx.doi.org/10.1084/jem.20080218
31. Milner, J.D., J.M. Brenchley, A. Laurence, A.F. Freeman, B.J. Hill, K.M. Elias, Y. Kanno, C. Spalding, H.Z. Elloumi, M.L. Paulson, et al. 2008. Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature. 452:773-776. http://dx.doi.org/10 .1038/nature06764
32. Minegishi, Y., M. Saito, S. Tsuchiya, I. Tsuge, H. Takada, T. Hara, N. Kawamura, T. Ariga, S. Pasic, O. Stojkovic, et al. 2007. Dominantnegative mutations in the DNA-binding domain of STAT3 cause hyper- IgE syndrome. Nature. 448:1058-1062. http://dx.doi.org/10.1038/ nature06096
33. Ness-Schwickerath, K.J., C. Jin, and C.T. Morita. 2010. Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22- producing human Vγ2Vδ2 T cells. J. Immunol. 184:7268-7280. http:// dx.doi.org/10.4049/jimmunol.1000600
34. Parker, C.M., V. Groh, H. Band, S.A. Porcelli, C. Morita, M. Fabbi, D. Glass, J.L. Strominger, and M.B. Brenner. 1990. Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire. J. Exp. Med. 171:1597-1612. http://dx.doi.org/10.1084/jem.171.5.1597
35. Puel, A., S. Cypowyj, J. Bustamante, J.F. Wright, L. Liu, H.K. Lim, M. Migaud, L. Israel, M. Chrabieh, M. Audry, et al. 2011. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science. 332:65-68. http://dx.doi.org/10.1126/science.1200439
36. Rachitskaya, A.V., A.M. Hansen, R. Horai, Z. Li, R. Villasmil, D. Luger, R.B. Nussenblatt, and R.R. Caspi. 2008. Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180:5167-5171. http://dx.doi.org/10.4049/jimmunol.180 .8.5167
37. Reantragoon, R., A.J. Corbett, I.G. Sakala, N.A. Gherardin, J.B. Furness, Z. Chen, S.B.G. Eckle, A.P. Uldrich, R.W. Birkinshaw, O. Patel, et al. 2013. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J. Exp. Med. 210:2305- 2320. http://dx.doi.org/10.1084/jem.20130958
38. Rossjohn, J., D.G. Pellicci, O. Patel, L. Gapin, and D.I. Godfrey. 2012. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12:845-857. http://dx.doi.org/10.1038/nri3328
39. Savage, A.K., M.G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity. 29:391-403. http://dx.doi.org/10.1016/j.immuni.2008.07.011
40. Shibata, K., H. Yamada, T. Sato, T. Dejima, M. Nakamura, T. Ikawa, H. Hara, S. Yamasaki, R. Kageyama, Y. Iwakura, et al. 2011. Notch- Hes1 pathway is required for the development of IL-17-producing γδT cells. Blood. 118:586-593. http://dx.doi.org/10.1182/blood-2011-02- 334995
41. Siegel, A.M., J. Heimall, A.F. Freeman, A.P. Hsu, E. Brittain, J.M. Brenchley, D.C. Douek, G.H. Fahle, J.I. Cohen, S.M. Holland, and J.D. Milner. 2011. A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity. 35:806-818. http://dx.doi.org/10.1016/j.immuni.2011.09.016
42. Stepensky, P., B. Keller, O. Abuzaitoun, A. Shaag, B. Yaacov, S. Unger, M. Seidl, M. Rizzi, M. Weintraub, O. Elpeleg, and K. Warnatz. 2015. Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency. Haematologica. 100:e72-e76. http://dx.doi.org/10 .3324/haematol.2014.112508
43. Wilson, N.J., K. Boniface, J.R. Chan, B.S. McKenzie, W.M. Blumenschein, J.D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17- producing helper T cells. Nat. Immunol. 8:950-957. http://dx.doi.org/ 10.1038/ni1497